Global Cough & Cold Remedies Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Cough & Cold Remedies Market Research Report 2024
Common cold and cough are minor disorders of respiratory system, usually arises due to infection in respiratory tract and autoimmune response.
According to Mr Accuracy reports’s new survey, global Cough & Cold Remedies market is projected to reach US$ million in 2034, increasing from US$ million in 2024, with the CAGR of % during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Cough & Cold Remedies market research.
Global Cold, Cough and Sore Throat Remedies market is projected to grow rapidly due to increasing incidences of cold, cough infections, economic price and wide availability of products and demand for rapid and long lasting effective products by the patients. Rising demand for such remedial products is one of the major factor influencing the market growth. Other major drivers includes, and a growing trend to self-diagnose and self-treat minor ailments and growth in the child, senior and female populations. For instance, considering the irritation caused by common cold, Novartis AG launched its formulation 'Otrivin Nasal Drops' that act against cold for around 12 hours, followed by a number of similar formulations. Owing to large number of available and upcoming products, the market is expected to grow rapidly. However, number of side effects, threat of resistance and large manufacturing cost and distribution are some of the key restraints that might hamper the growth of the market.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Cough & Cold Remedies market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Reckitt Benckiser
Johnson & Johnson
GlaxoSmithKline
Novartis
Bayer
AstraZeneca
Sun Pharmaceutical Industries
Pfizer
Prestige Brands
Segment by Type
Antihistamines
Expectorants
Bronchodilators
Decongestants
Antibiotics
Others
Hospital Pharmacies
Retail Pharmacies
Drug Stores
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Cough & Cold Remedies report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global Cough & Cold Remedies market is projected to reach US$ million in 2034, increasing from US$ million in 2024, with the CAGR of % during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Cough & Cold Remedies market research.
Global Cold, Cough and Sore Throat Remedies market is projected to grow rapidly due to increasing incidences of cold, cough infections, economic price and wide availability of products and demand for rapid and long lasting effective products by the patients. Rising demand for such remedial products is one of the major factor influencing the market growth. Other major drivers includes, and a growing trend to self-diagnose and self-treat minor ailments and growth in the child, senior and female populations. For instance, considering the irritation caused by common cold, Novartis AG launched its formulation 'Otrivin Nasal Drops' that act against cold for around 12 hours, followed by a number of similar formulations. Owing to large number of available and upcoming products, the market is expected to grow rapidly. However, number of side effects, threat of resistance and large manufacturing cost and distribution are some of the key restraints that might hamper the growth of the market.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Cough & Cold Remedies market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Reckitt Benckiser
Johnson & Johnson
GlaxoSmithKline
Novartis
Bayer
AstraZeneca
Sun Pharmaceutical Industries
Pfizer
Prestige Brands
Segment by Type
Antihistamines
Expectorants
Bronchodilators
Decongestants
Antibiotics
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Cough & Cold Remedies report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices